Cancer Family
Digestive System Hematopoietic and Lymphoid Cell Neoplasm
CI-CAN-00000162Explore in graph →
HematologicNon-malignant15 active trials
- NCIt
- C213901
Loading cancer entity…
Cancer Family
CI-CAN-00000162Explore in graph →
Clinical trials
119 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04021082 | CELTIC-1: A Phase 2B Study of Cerdulatinib in Patients With Relapsed/Refractory Peripheral T-Cell Lymphoma (PTCL) | withdrawn | Phase 2 / Phase 3 | 0 | Portola PharmaceuticalsINDUSTRY | 0 | Feb 21, 2023 | clinicaltrials |
Data updated 22 days agoSource updated Feb 21, 2023source: clinicaltrials